LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 4 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 1. - Dataset (ID:20312)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 85.30 | 770.96 | 9036 | 12277 | 0.7359 | 0.8442 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.50 | 770.96 | 9167 | 12567 | 0.7297 | 0.8409 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.90 | 770.96 | 811 | 886 | 0.9161 | 0.3321 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.10 | 770.96 | 935 | 984 | 0.9504 | 0.7635 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.30 | 770.96 | 1013 | 1067 | 0.9493 | 0.8028 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.60 | 770.96 | 1102 | 1178 | 0.9363 | 0.8020 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 11.90 | 770.96 | 1218 | 1319 | 0.9243 | 0.8100 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.10 | 770.96 | 1329 | 1478 | 0.8990 | 0.7859 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.40 | 770.96 | 1392 | 1625 | 0.8571 | 0.7328 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.60 | 770.96 | 1485 | 1786 | 0.8317 | 0.7180 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 20.80 | 770.96 | 1579 | 1959 | 0.8061 | 0.7034 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.00 | 770.96 | 1686 | 2193 | 0.7693 | 0.6800 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.30 | 770.96 | 1818 | 2456 | 0.7407 | 0.6703 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.50 | 770.96 | 1964 | 2754 | 0.7138 | 0.6635 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.70 | 770.96 | 2103 | 3022 | 0.6965 | 0.6636 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.90 | 770.96 | 2261 | 3294 | 0.6869 | 0.6705 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.10 | 770.96 | 2418 | 3605 | 0.6712 | 0.6707 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.40 | 770.96 | 2566 | 3985 | 0.6443 | 0.6604 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.60 | 770.96 | 2757 | 4421 | 0.6241 | 0.6577 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 40.80 | 770.96 | 2957 | 4874 | 0.6073 | 0.6568 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.00 | 770.96 | 3168 | 5280 | 0.6004 | 0.6630 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.30 | 770.96 | 3348 | 5677 | 0.5901 | 0.6640 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.50 | 770.96 | 3565 | 6082 | 0.5866 | 0.6708 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.70 | 770.96 | 3743 | 6511 | 0.5751 | 0.6699 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.90 | 770.96 | 3978 | 6944 | 0.5732 | 0.6767 |